By Vincent Cruz

British beauty brands have a natural advantage in the American market: shared language, strong brand storytelling, and a reputation for quality. But regulatory advantage is not one of them. Post-Brexit, the UK’s cosmetics regime and America’s MoCRA framework are entirely separate systems, and compliance in one buys you nothing in the other.

This guide is written for the UK brand owner planning a U.S. launch: what MoCRA requires of you, where UK and U.S. rules diverge, and the specific mistakes that catch British brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.

The core rule: UK compliance does not transfer

Everything in this guide follows from one fact: FDA does not recognize UK or EU compliance as a substitute for U.S. compliance. Specifically:

Your UK Responsible Person has no standing with FDA. MoCRA has its own “responsible person” concept (the manufacturer, packer, or distributor whose name appears on the label), and it is a different legal role.
Your CPNP notification (the EU/UK cosmetic product notification) means nothing to FDA. The U.S. has its own product listing system.
Your UKCA marking, GMP certificates, and safety assessments are useful evidence of good practice, but none of them satisfies a U.S. filing requirement.
Post-Brexit UK regulations (the UK Cosmetics Regulation, based on the old EU regulation) continue to evolve separately from both EU and U.S. rules. You are now managing three regimes, not two.

Plan your U.S. launch as a fresh compliance project, not an extension of your UK paperwork.

Step 1: Register your facility with FDA

If your products are manufactured or processed in the UK (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for UK brands:

You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
Using a UK contract manufacturer? The facility that manufactures the product is the one that registers. If you outsource to a UK lab, that lab’s facility registers (and it needs its own U.S. agent). See Private Label Cosmetics: Who Registers Under MoCRA.

A common UK-brand mistake: assuming your American distributor’s registration covers you. It does not. The manufacturing facility registers; a distributor cannot register on the manufacturer’s behalf.

Step 2: Name a U.S. agent

Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and a UK address or your UK Responsible Person cannot fill the role.

The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.

Step 3: List your products

Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person. Listings include product and ingredient information and must be kept current with annual updates.

Note the UK difference: the EU/UK system notifies products before market placement through CPNP; the U.S. system lists them with FDA under a different data format and different legal consequences. Do both; neither substitutes for the other. For how registration and listing differ, see Facility Registration vs Product Listing Explained.

Step 4: Fix your labels for the U.S. market

UK labels do not automatically comply with U.S. labeling law. The differences that matter most:

Ingredient declaration. Both markets use INCI-style nomenclature, so your ingredient list mostly transfers. But the U.S. requires ingredients in descending order of predominance with specific formatting rules, and FDA is developing fragrance allergen labeling regulations that will add new disclosure requirements.

Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. UK labels showing metric only need updating.

Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. A UK address alone is acceptable only if the product is not misleading about origin; many UK brands add their U.S. distributor’s information.

Identity statement. The common or usual name of the product must appear prominently. UK “descriptive” naming usually satisfies this, but verify.

Warnings and directions. Certain product types require specific warning statements under U.S. rules. Products also regulated as drugs need Drug Facts labeling instead.

Language. All required label information must be in English and must be prominent and conspicuous.

Claims review. Marketing claims written for the UK market can be drug claims in the U.S. “Repairs skin barrier,” “reduces inflammation,” or SPF claims need re-evaluation before the product ships. See Is Your Product a Cosmetic or a Drug?; this is the single most common UK-to-US failure point, especially for SPF products (cosmetics in the UK, drugs in the U.S.).

For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.

The pitfalls that catch UK brands specifically

Assuming EU/UK compliance equals U.S. compliance. It does not, in any respect. Separate filings, separate labels, separate agent.
SPF and suncare products. Regulated as cosmetics in the UK, as drugs in the U.S. A British sunscreen brand faces an entirely different FDA pathway. Get classification advice before spending on a launch.
Relying on the distributor. Your U.S. distributor or retail partner may offer to “handle compliance.” They cannot register your UK facility or serve as your facility’s U.S. agent unless they formally take on that role and meet FDA’s requirements. Keep control of your own filings.
Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not UK turnover, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and record-keeping that FDA can demand to see. See MoCRA Adverse Event Reporting.

A realistic UK-to-US launch sequence

Classify every product as cosmetic or drug for the U.S. market (re-do claims and ingredients, not just labels).
Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
Request your facility’s FEI number (7 to 10 business days).
Choose and appoint your U.S. agent.
File facility registration via Cosmetics Direct.
File product listings.
Finalize U.S.-compliant labels before the first shipment.
Set up adverse event intake and record-keeping from day one.

For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.

FAQ

Do I need a U.S. agent if I sell through an American distributor?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration. Your distributor cannot substitute for this unless it formally serves as the agent and meets FDA’s requirements.

Does my CPNP notification count as a U.S. product listing?
No. The UK/EU notification system and the U.S. listing system are completely separate. You must list products with FDA through Cosmetics Direct regardless of CPNP status.

Can my UK Responsible Person be my U.S. agent?
No. The U.S. agent must be physically present in the United States (residing there or maintaining a U.S. place of business). A UK-based person or company does not qualify.

Are UK cosmetic labels acceptable in the US?
Usually not without changes. Net quantity declarations, name and place of business, warning statements, and claims all need review against U.S. requirements. Ingredient nomenclature mostly transfers, but formatting rules differ.

My products contain SPF. What changes?
In the U.S., sunscreen products are regulated as drugs, not cosmetics. This means a different FDA registration and listing system, Drug Facts labeling, and drug manufacturing standards. Get classification advice before launching suncare in America.

How long does the whole process take for a UK brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.

Next step: UK brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.